 |
|
Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
Yun-Ji Kim, Inha Lee, Young Shin Chung, EunJi Nam, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim, Jung-Yun Lee
Obstet Gynecol Sci. 2018;61(2):227-234. Published online 2018 Feb 5 DOI: https://doi.org/10.5468/ogs.2018.61.2.227
|
|
Citations to this article as recorded by
 Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR
Chuan-long Zhang, Xiao-chen Jiang, Yi Li, Xue Pan, Meng-qi Gao, Yan Chen, Bo Pang
Journal of Ovarian Research.2023;[Epub] CrossRef Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators—a review
Alexandra-Ligia Dinca, Adriana Diaconu, Rodica Daniela Birla, Bogdan-Ioan Coculescu, Valeriu-Gabi Dinca, Gheorghe Manole, Cristian Marica, Ioan Sorin Tudorache, Eugenia Panaitescu, Silviu Marian Constantinoiu, Elena Claudia Coculescu
International Journal of Immunopathology and Pharmacology.2023; 37: 039463202311787. CrossRef Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer
Michal Mleko, Elzbieta Pluta, Kazimierz Pitynski, Maciej Bodzek, Andrzej Kałamacki, Dorota Kiprian, Tomasz Banas
Cancers.2023; 15(14): 3607. CrossRef Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery
Andrea Plaja, Iris Teruel, Maria Ochoa-de-Olza, Marc Cucurull, Álvaro Javier Arroyo, Beatriz Pardo, Irene Ortiz, Marta Gil-Martin, Josep María Piulats, Helena Pla, Claudia Fina, Anna Carbó, Maria-Pilar Barretina-Ginesta, Sergio Martínez-Román, Elvira Carb
International Journal of Molecular Sciences.2023; 24(14): 11420. CrossRef Prognostic value of neutrophil-to-lymphocyte ratio and fibrinogen levels in ovarian cancer
Roudhona Rosaudyn, Faradillah Mutiani, Indra Yuliati, Birama Robby Indraprasta
Medical Journal of Indonesia.2023; 32(2): 86. CrossRef The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease
Eliza Russu, Adrian Vasile Mureșan, Emil Marian Arbănași, Réka Kaller, Ioan Hosu, Septimiu Voidăzan, Eliza Mihaela Arbănași, Cătălin Mircea Coșarcă
Journal of Clinical Medicine.2022; 11(9): 2620. CrossRef Survival analysis of 80 elderly patients with esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy with S-1
J.-J. Ran, J.-J. Shen, J. Ma, X.-Y. Li
Cancer/Radiothérapie.2022; 26(8): 1064. CrossRef Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
Santhosh Anand, Gajendra Bhati, Ramprakash Gurram, Senthil Gnanasekaran, Vikram Kate, Biju Pottakkat, Raja Kalayarasan
Journal of Gastrointestinal Cancer.2021; 52(2): 659. CrossRef Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancer
Giuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
Cancer Immunology, Immunotherapy.2021; 70(4): 1115. CrossRef Chemotherapy Response Score Predicts Surgical Outcome and Prognosis in Tubo-Ovarian/Primary Peritoneal Cancers: A Retrospective Analysis in a Tertiary Care Centre in UK
Anirban Dasgupta, Nana Gomes, Asima Mukhopadhyay, Ali Kucukmetin
Indian Journal of Gynecologic Oncology.2021;[Epub] CrossRef Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, M. Kaparelou, N. Thomakos, D. Haidopoulos, A. Rodolakis, M. A. Dimopoulos, F. Zagouri
Journal of Ovarian Research.2021;[Epub] CrossRef The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer
Varol Gülseren, İlker Çakır, İsa Aykut Özdemir, Muzaffer Sancı, Mehmet Gökçü, Kemal Güngördük
Current Problems in Cancer.2020; 44(4): 100536. CrossRef Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R. Madiyalakan, Yolanda D. Mahnke, Christopher Nicodemus
Cancer Immunology, Immunotherapy.2020; 69(3): 383. CrossRef Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma
A G M T Powell, C Chin, A H Coxon, A Chalishazar, A Christian, S A Roberts, W G Lewis
BJS Open.2020; 4(3): 416. CrossRef Advances in Blood Predictors of Gestational Trophoblast Disease
小霞 王
Advances in Clinical Medicine.2020; 10(09): 2024. CrossRef Extreme skeletal muscle loss during induction chemotherapy is an independent predictor of poor survival in advanced epithelial ovarian cancer patients
Yasunori Yoshino, Ayumi Taguchi, Yujiro Nakajima, Maki Takao, Tomoko Kashiyama, Akiko Furusawa, Nao Kino, Toshiharu Yasugi
Journal of Obstetrics and Gynaecology Research.2020; 46(12): 2662. CrossRef Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
Asami Ikeda, Ken Yamaguchi, Hajime Yamakage, Kaoru Abiko, Noriko Satoh-Asahara, Kenji Takakura, Ikuo Konishi
Obstetrics & Gynecology Science.2020; 63(6): 709. CrossRef Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer
Yasunori Yoshino, Ayumi Taguchi, Maki Takao, Tomoko Kashiyama, Akiko Furusawa, Masaya Uno, Satoshi Okada, Nao Kino, Toshiharu Yasugi
International Journal of Clinical Oncology.2019; 24(4): 428. CrossRef
|